眩晕宁联合甲磺酸倍他司汀治疗后循环缺血性眩晕疗效观察

Observation of Therapeutic Effect of Vertigo Combined With Methylene Sulfonic Acid in the Treatment of Posterior Circulation Ischemia Vertigo

目的观察眩晕宁与甲磺酸倍他司汀(敏使朗)联合治疗后循环缺血性眩晕的临床疗效。方法随机选择80例后循环缺血眩晕患者,分别给予甲磺酸倍他司汀片和加用眩晕宁片治疗,比较临床疗效及椎-基底动脉平均血流速度。结果经临床治疗后,治疗组总有效率(92.5%)高于对照组(82.5%);血流速度改善率治疗组优于对照组(P<0.05)。结论眩晕宁联合甲磺酸倍他司汀治疗后循环缺血性眩晕的疗效优于甲磺酸倍他司汀单药治疗,联合用药具有协同作用。

Objective To investigate the vertigo and betahistine mesylate （Min enable Lang） after combined treatment of ischemic clinical efifcacy cycle vertigo. Methods 80 cases circulation ischemia vertigo patients were treated with betahistine mesylate tablets tablets treatment and processing with vertigo, compare the clinical efficacy and vertebral-basilar artery mean lfow velocity. Results after clinical treatment, the total efifciency of the treatment group （92.5%） was higher （82.5%）, the rate of blood flow velocity to improve the treatment group than the control group （P〈0.05）. Conclusion Dizziness Ning joint betahistine mesylate treatment of posterior circulation ischemia vertigo effective than betahistine mesylate monotherapy, combination therapy has a synergistic effect.